ORGANISATION/COMPANYUniversité Libre de Bruxelles (ULB)
RESEARCH FIELDBiological sciences › BiologyMedical sciences › Other
RESEARCHER PROFILERecognised Researcher (R2)
APPLICATION DEADLINE30/06/2017 18:00 - Europe/Brussels
LOCATIONBelgium › Brussels
TYPE OF CONTRACTTemporary
HOURS PER WEEK38
Applications are invited for one to two postdoctoral positions at the ULB Center for Diabetes Research, Universite Libre de Bruxelles, Brussels, Belgium for projects funded by the EC, IMI, HIRN and Welbio-FNRS, Belgium. We study the role for alternative splicing in pancreatic beta-cell dysfunction and death in diabetes mellitus and the generation of novel auto-antigens, and search for novel biomarkers of beta cell dysfunction and death. iPSC-derived pre-beta cells are important tools for this research line. An overview of our research lines can be found in Eizirik DL et al. Nature Rev Endocrinol. 5, 219–226, 2009; Eizirik DL et al. PLoS Genet 8: e1002552, 2012; Nogueira T et al. PLoS Genet, 9: e1003532, 2013; Villate O et al., Nucleic Acid Res 42: 11818-11830, 2014; Marroqui L et al., eLife, 4: e06990, 2015; Op de Beeck A and Eizirik DL, Nature Rev Endocrinol, 12:263-273, 2016; Ben-Othman N et al. Cell, 168: 73-85, 2017; Juan-Mateu J et al. J Biol Chem, 292:3466-3480, 2017; Marroqui L et al., Diabetologia, 60:656-667, 2017.
A solid knowledge of molecular biology, particularly applied to alternative splicing or of iPSC-derived beta cells, is important for the position. These 2-year postdoctoral positions (with possibility of renewal) start in October/November 2017 (starting date can be negotiated) and the positions will remain open until suitable candidates are found.
Please email a letter of interest, curriculum vitae (including publication list), and the name of 2-3 reference persons to:
Prof. Decio L. Eizirik
ULB Center for Diabetes Research
Faculty of Medicine
Universite Libre de Bruxelles
EURAXESS offer ID: 198515